Our findings strongly emphasize the crucial role of this novel pathway in driving metastatic tumor progression and demonstrate that targeting mutp53 stability, the CANX/CALR cycle, or ITGA5 can effectively interfere with mutp53-mediated pro-metastatic functions. The gene discussed is CANX; the disease is neoplasm.